TY - STAND
AU - A. Root
AU - A . Y. Wong
AU - Y. Ghebremichael-Weldeselassie
AU - L. Smeeth
AU - K. Bhaskaran
AU - S. Evans
AU - R. Brauer
AU - I. Wong
AU - V. Navaratnam
AU - I. Douglas
BT - Br J Clin Pharmacol
DO - 10.1111/bcp.12983
M1 - 2
PY - 2016
SP - 512
EP - 21
T2 - Br J Clin Pharmacol
TI - Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs
VL - 82
SN - 0306-5251
ER -